Common Genetic Variations Associated with the Persistence of Immunity following Childhood Immunization.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
11 06 2019
Historique:
received: 22 10 2018
revised: 25 01 2019
accepted: 15 05 2019
entrez: 13 6 2019
pubmed: 13 6 2019
medline: 4 8 2020
Statut: ppublish

Résumé

Vaccines have revolutionized public health, preventing millions of deaths each year, particularly in childhood. Yet, there is considerable variability in the magnitude and persistence of vaccine-induced immunity. Maintenance of specific antibody is essential for continuity of vaccine-induced serological protection. We conducted a genome-wide association study into the persistence of immunity to three childhood vaccines: capsular group C meningococcal (MenC), Haemophilus influenzae type b, and tetanus toxoid (TT) vaccines. We detail associations between variants in a locus containing a family of signal-regulatory proteins and the persistence MenC immunity. We postulate a regulatory role for the lead SNP, with supporting epigenetic and expression quantitative trait loci data. Furthermore, we define associations between SNPs in the human leukocyte antigen (HLA) locus and the persistence of TT-specific immunity. Moreover, we describe four classical HLA alleles, HLA DRB1

Identifiants

pubmed: 31189108
pii: S2211-1247(19)30682-5
doi: 10.1016/j.celrep.2019.05.053
pii:
doi:

Substances chimiques

HLA Antigens 0
Haemophilus Vaccines 0
Meningococcal Vaccines 0
Tetanus Toxoid 0
serogroup C meningococcal conjugate vaccine 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3241-3253.e4

Subventions

Organisme : Department of Health
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Daniel O'Connor (D)

Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: daniel.oconnor@paediatrics.ox.ac.uk.

Eileen Png (E)

Infectious Diseases, Genome Institute of Singapore, Singapore, Singapore.

Chiea Chuen Khor (CC)

Infectious Diseases, Genome Institute of Singapore, Singapore, Singapore.

Matthew D Snape (MD)

Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.

Adrian V S Hill (AVS)

NIHR Oxford Biomedical Research Centre, Oxford, UK; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Fiona van der Klis (F)

Centre for Infectious Disease Control Netherlands, RIVM, Bilthoven, the Netherlands.

Clive Hoggart (C)

Division of Infectious Diseases, Department of Medicine, Imperial College London, London, UK.

Michael Levin (M)

Division of Infectious Diseases, Department of Medicine, Imperial College London, London, UK.

Martin L Hibberd (ML)

Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; Department of Pathogen Molecular Biology, London School of Hygiene & Tropical Medicine, London, UK.

Andrew J Pollard (AJ)

Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH